The global burden of tuberculosis (TB) is still large. The increasing incidence of drug-
resistant, multidrug-resistant (MDR)(resistant to at least rifampicin and isoniazid), and …

This minireview presents recent developments in molecular methods for the diagnosis of
tuberculosis, including detection, identification and determination of drug resistance of …

The task of rapidly identifying patients infected with Mycobacterium tuberculosis in resource-
constrained environments remains a challenge. A sensitive and robust platform that does …

The past 10 years have seen the most rapid growth in new diagnostics for Mtb in over a
century. Although these tests offer improvements in the ability to detect Mtb, drug-resistant …

In this review, we describe the phenotypic and genotypic methods currently available for the
diagnosis of TB and drug-resistant forms of Mycobacterium tuberculosis and discuss future …

With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug
susceptibility testing (DST) of Mycobacterium tuberculosis to first-line drugs has become …

With the emergence of multidrug-resistant tuberculosis (MDR-TB), the need for rapid drug
susceptibility testing (DST) is felt globally. National tuberculosis control programmes (NTPs) …

Tuberculosis (TB) remains an impactful infectious disease, leading to millions of deaths
every year. Mycobacterium tuberculosis causes the formation of granulomas, which will …

Tuberculosis remains one of the major causes of global death from a single infectious agent.
This situation is worsened by the HIV/AIDS pandemic because one-third of HIV/AIDS …

Antibiotic resistance is exponentially increasing, and the number of deaths caused by
bacterial infections is expected to surge. When dealing with the respiratory system …